Quarter Financials

Relmada Therapeutics, Inc. (RLMD)

$2.6

-0.21 (-7.47%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2
Net Income -26-38-39-40-40-34-43-27
Dividend Paid --------
Retained Earnings -488-462-424-385-345-305-271-228

PPE Schedule

Year 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2
Capital Expenditure --------
Net PPE --------

Intangible and Goodwill Schedule

Year 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2
New Purchases -36-26-141-26-7-6-8-35
Intangible and Goodwill --------